{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:03:03Z","timestamp":1783137783037,"version":"3.54.6"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11102-024-01449-1","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T12:02:27Z","timestamp":1725019347000},"page":"440-443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Does size really matter? A closer look at the absolute size of growth hormone-secreting pituitary adenomas"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8667-0296","authenticated-orcid":false,"given":"Katharina","family":"Schilbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Raverot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"1449_CR1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1530\/EJE-20-0019","volume":"182","author":"D Esposito","year":"2020","unstructured":"Esposito D, Ragnarsson O, Johannsson G, Olsson DS (2020) Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur J Endocrinol 182:523\u2013531. https:\/\/doi.org\/10.1530\/EJE-20-0019","journal-title":"Eur J Endocrinol"},{"key":"1449_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1530\/EJE-21-0729","volume":"186","author":"S Arnard\u00f3ttir","year":"2022","unstructured":"Arnard\u00f3ttir S, J\u00e4r\u00e5s J, Burman P et al (2022) Long-term outcomes of patients with acromegaly: a report from the Swedish pituitary register. Eur J Endocrinol 186:329\u2013339. https:\/\/doi.org\/10.1530\/EJE-21-0729","journal-title":"Eur J Endocrinol"},{"key":"1449_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3803\/EnM.2014.29.4.450","volume":"29","author":"JY Park","year":"2014","unstructured":"Park JY, Kim JH, Kim SW et al (2014) Using growth hormone levels to detect macroadenoma in patients with acromegaly. Endocrinol Metab Seoul Korea 29:450\u2013456. https:\/\/doi.org\/10.3803\/EnM.2014.29.4.450","journal-title":"Endocrinol Metab Seoul Korea"},{"key":"1449_CR4","doi-asserted-by":"publisher","first-page":"807054","DOI":"10.3389\/fendo.2021.807054","volume":"12","author":"X Guo","year":"2021","unstructured":"Guo X, Zhang R, Zhang D et al (2021) Hyperprolactinemia and hypopituitarism in acromegaly and effect of pituitary surgery: long-term follow-up on 529 patients. Front Endocrinol 12:807054. https:\/\/doi.org\/10.3389\/fendo.2021.807054","journal-title":"Front Endocrinol"},{"key":"1449_CR5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0254","author":"F Bonneville","year":"2018","unstructured":"Bonneville F, Rivi\u00e8re L-D, Petersenn S et al (2018) MRI T2 signal intensity and tumor response in patients with GH-secreting pituitary macroadenoma: PRIMARYS post-hoc analysis. Eur J Endocrinol EJE. https:\/\/doi.org\/10.1530\/EJE-18-0254. -18-0254.R2","journal-title":"Eur J Endocrinol EJE"},{"key":"1449_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s11102-020-01063-x","volume":"23","author":"N Agrawal","year":"2020","unstructured":"Agrawal N, Ioachimescu AG (2020) Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: a structured review. Pituitary 23:582\u2013594. https:\/\/doi.org\/10.1007\/s11102-020-01063-x","journal-title":"Pituitary"},{"key":"1449_CR7","doi-asserted-by":"publisher","unstructured":"Del Corso LM, Mesa Junior CO, Andrade VFC et al (2024) Diagnostic, therapeutic, and prognostic characteristics of patients with acromegaly according to tumor size at diagnosis. Pituitary. https:\/\/doi.org\/10.1007\/s11102-024-01432-w","DOI":"10.1007\/s11102-024-01432-w"},{"key":"1449_CR8","first-page":"617","volume":"87","author":"IA Osman","year":"1994","unstructured":"Osman IA, James RA, Chatterjee S et al (1994) Factors determining the long-term outcome of surgery for acromegaly. QJM Mon J Assoc Physicians 87:617\u2013623","journal-title":"QJM Mon J Assoc Physicians"},{"key":"1449_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1046\/j.1365-2265.1999.00760.x","volume":"50","author":"S Ahmed","year":"1999","unstructured":"Ahmed S, Elsheikh M, Stratton IM et al (1999) Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol (Oxf) 50:561\u2013567. https:\/\/doi.org\/10.1046\/j.1365-2265.1999.00760.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1449_CR10","doi-asserted-by":"publisher","first-page":"101342","DOI":"10.1016\/j.ghir.2020.101342","volume":"55","author":"H Diri","year":"2020","unstructured":"Diri H, Ozaslan E, Kurtsoy A, Bayram F (2020) A single-center observational study assessing the predictive factors associated with the prognosis of acromegaly. Growth Horm IGF Res off J Growth Horm Res Soc Int IGF Res Soc 55:101342. https:\/\/doi.org\/10.1016\/j.ghir.2020.101342","journal-title":"Growth Horm IGF Res off J Growth Horm Res Soc Int IGF Res Soc"},{"key":"1449_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3171\/2017.2.JNS162673","volume":"129","author":"JP Almeida","year":"2018","unstructured":"Almeida JP, Ruiz-Trevi\u00f1o AS, Liang B et al (2018) Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature. J Neurosurg 129:404\u2013416. https:\/\/doi.org\/10.3171\/2017.2.JNS162673","journal-title":"J Neurosurg"},{"key":"1449_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1055\/s-0029-1239506","volume":"42","author":"M Luque-Ram\u00edrez","year":"2010","unstructured":"Luque-Ram\u00edrez M, Portoles GR, Varela C et al (2010) The efficacy of octreotide LAR as firstline therapy for patients with newly diagnosed acromegaly is independent of tumor extension: predictive factors of tumor and biochemical response. Horm Metab Res Horm Stoffwechselforschung Horm Metab 42:38\u201344. https:\/\/doi.org\/10.1055\/s-0029-1239506","journal-title":"Horm Metab Res Horm Stoffwechselforschung Horm Metab"},{"key":"1449_CR13","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1210\/clinem\/dgab901","volume":"107","author":"MR Gadelha","year":"2022","unstructured":"Gadelha MR, Barbosa MA, Lamback EB et al (2022) Pituitary MRI standard and advanced sequences: role in the diagnosis and characterization of pituitary adenomas. J Clin Endocrinol Metab 107:1431\u20131440. https:\/\/doi.org\/10.1210\/clinem\/dgab901","journal-title":"J Clin Endocrinol Metab"},{"key":"1449_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s11102-019-01023-0","volume":"23","author":"BP Galm","year":"2020","unstructured":"Galm BP, Buckless C, Swearingen B et al (2020) MRI texture analysis in acromegaly and its role in predicting response to somatostatin receptor ligands. Pituitary 23:212\u2013222. https:\/\/doi.org\/10.1007\/s11102-019-01023-0","journal-title":"Pituitary"},{"key":"1449_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1053\/j.semnuclmed.2023.02.005","volume":"53","author":"D Gillett","year":"2023","unstructured":"Gillett D, MacFarlane J, Bashari W et al (2023) Molecular imaging of pituitary tumors. Semin Nucl Med 53:530\u2013538. https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.02.005","journal-title":"Semin Nucl Med"},{"key":"1449_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1365-2265.2011.04286.x","volume":"77","author":"A Heck","year":"2012","unstructured":"Heck A, Ringstad G, Fougner SL et al (2012) Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly. Clin Endocrinol (Oxf) 77:72\u201378. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04286.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1449_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1530\/EJE-19-0840","volume":"182","author":"EC Coopmans","year":"2020","unstructured":"Coopmans EC, Schneiders JJ, El-Sayed N et al (2020) T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly. Eur J Endocrinol 182:595\u2013605. https:\/\/doi.org\/10.1530\/EJE-19-0840","journal-title":"Eur J Endocrinol"},{"key":"1449_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/cen.14946","volume":"99","author":"S Ruiz","year":"2023","unstructured":"Ruiz S, Gil J, Biagetti B et al (2023) Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly. Clin Endocrinol (Oxf) 99:378\u2013385. https:\/\/doi.org\/10.1111\/cen.14946","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1449_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1530\/ERC-14-0305","volume":"22","author":"I Potorac","year":"2015","unstructured":"Potorac I, Petrossians P, Daly AF et al (2015) Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences. Endocr Relat Cancer 22:169\u2013177. https:\/\/doi.org\/10.1530\/ERC-14-0305","journal-title":"Endocr Relat Cancer"},{"key":"1449_CR20","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1210\/clinem\/dgac512","volume":"107","author":"M-D Ilie","year":"2022","unstructured":"Ilie M-D, Tabarin A, Vasiljevic A et al (2022) Predictive factors of somatostatin receptor ligand response in acromegaly-A prospective study. J Clin Endocrinol Metab 107:2982\u20132991. https:\/\/doi.org\/10.1210\/clinem\/dgac512","journal-title":"J Clin Endocrinol Metab"},{"key":"1449_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.humpath.2013.08.007","volume":"45","author":"L Chinezu","year":"2014","unstructured":"Chinezu L, Vasiljevic A, Jouanneau E et al (2014) Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies. Hum Pathol 45:71\u201377. https:\/\/doi.org\/10.1016\/j.humpath.2013.08.007","journal-title":"Hum Pathol"},{"key":"1449_CR22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11102-023-01345-0","volume":"26","author":"A Giustina","year":"2023","unstructured":"Giustina A, Uygur MM, Frara S et al (2023) Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers. Pituitary 26:583\u2013596. https:\/\/doi.org\/10.1007\/s11102-023-01345-0","journal-title":"Pituitary"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01449-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01449-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01449-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T04:56:24Z","timestamp":1730868984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01449-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1449"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01449-1","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"15 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}